remdesivir

FDA expands emergency use of Gilead’s remdesivir in hospitalized COVID-19 patients

This post was originally published on this siteGilead Inc said on Friday the U.S. Food and Drug Administration expanded the emergency use authorization of its experimental antiviral COVID-19

Read More

Gilead Gains Expanded FDA Authorization for COVID-19 Treatment Remdesivir

This post was originally published on this siteGilead Sciences (NASDAQ:GILD) gained expanded emergency use authorization from the Food and Drug Administration for its COVID-19 treatment

Read More

NIH to study remdesivir-esque Gilead compound as potential COVID-19 treatment

This post was originally published on this siteThe National Institutes of Health will conduct independent trials investigating the effectiveness of GS-441524, a Gilead drug compound that bears

Read More

Remdesivir disappoints in COVID-19 study; breast milk transmission unlikely

This post was originally published on this site(Reuters) – The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and

Read More

Remdesivir May Only Provide Modest Benefit Against ‘Moderate’ COVID-19

This post was originally published on this siteBy E.J. Mundell HealthDay Reporter. FRIDAY, Aug. 21, 2020 (HealthDay News) — The antiviral drug remdesivir has been one of the few treatments

Read More

Remdesivir may NOT be effective in treating COVID-19 in moderate cases, new study finds

This post was originally published on this siteRemdesvir is the only drug in the US approved for emergency use in patients with severe cases of coronavirus; In a new study of moderate cases,

Read More

US to test benefits of remdesivir with second drug

This post was originally published on this siteThe U.S. has begun the third phase of its remdesivir study, testing the antiviral drug’s effectiveness in treating COVID-19 when taken

Read More

Gilead seeks FDA approval for COVID-19 drug remdesivir, gives it a brand name

This post was originally published on this siteGilead Sciences applied for approval from the FDA for its experimental COVID-19 treatment remdesivir on Aug. 10. The drug will go by the brand name

Read More

Gilead Submits New-Drug Application for Remdesivir

This post was originally published on this siteGilead Sciences (GILD) – Get Report shares fell Monday after the company submitted a new-drug application to the U.S. Food and Drug

Read More

Pfizer to Co-Manufacture Coronavirus Drug Remdesivir

This post was originally published on this siteThe company is pitching in to produce Gilead’s antiviral treatment, which received emergency use authorization in May. Eric Volkman.

Read More